Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis

Andreas Ronit; Anders Porskrog; Sarah Djebara; Sigrid Bergmann; Jean-Paul Pirnay; Maia Merabishvili; Toke S Barfod; Kim Thomsen; Christian T Brandt

doi:10.61409/V09230617

Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis

Andreas Ronit, Anders Porskrog, Sarah Djebara, Sigrid Bergmann, Jean-Paul Pirnay, Maia Merabishvili, Toke S Barfod, Kim Thomsen, Christian T Brandt

Infektionsmedicinsk Afdeling

1 Citationer (Scopus)

Abstract

We present a case report detailing therapeutic application of two lytic antipseudomonal bacteriophages to treat a chronic relapsing Pseudomonas aeruginosa infection of a prosthetic aortic graft. As there are currently no Danish laboratories offering phages for clinical therapy, and this case, to our knowledge represents the first applied phage therapy in Denmark, the practical and regulatory aspects of offering this treatment option in Denmark is briefly reviewed along with the clinical case.

Bidragets oversatte titel	Not Available
Originalsprog	Dansk
Artikelnummer	V09230617
Tidsskrift	Ugeskrift for Laeger
Vol/bind	186
Udgave nummer	3
ISSN	0041-5782
DOI	https://doi.org/10.61409/V09230617
Status	Udgivet - 22 jan. 2024

Emneord

Humans
Bacteriophages
Pseudomonas
Pseudomonas Phages
Blood Vessel Prosthesis
Pseudomonas aeruginosa

Adgang til dokumentet

10.61409/V09230617

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{4de7d6da0bbe4f9085df4b3d920b9b9f,

title = "Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis",

abstract = "We present a case report detailing therapeutic application of two lytic antipseudomonal bacteriophages to treat a chronic relapsing Pseudomonas aeruginosa infection of a prosthetic aortic graft. As there are currently no Danish laboratories offering phages for clinical therapy, and this case, to our knowledge represents the first applied phage therapy in Denmark, the practical and regulatory aspects of offering this treatment option in Denmark is briefly reviewed along with the clinical case.",

keywords = "Humans, Bacteriophages, Pseudomonas, Pseudomonas Phages, Blood Vessel Prosthesis, Pseudomonas aeruginosa",

author = "Andreas Ronit and Anders Porskrog and Sarah Djebara and Sigrid Bergmann and Jean-Paul Pirnay and Maia Merabishvili and Barfod, {Toke S} and Kim Thomsen and Brandt, {Christian T}",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = jan,

day = "22",

doi = "10.61409/V09230617",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "3",

}

TY - JOUR

T1 - Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis

AU - Ronit, Andreas

AU - Porskrog, Anders

AU - Djebara, Sarah

AU - Bergmann, Sigrid

AU - Pirnay, Jean-Paul

AU - Merabishvili, Maia

AU - Barfod, Toke S

AU - Thomsen, Kim

AU - Brandt, Christian T

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/1/22

Y1 - 2024/1/22

N2 - We present a case report detailing therapeutic application of two lytic antipseudomonal bacteriophages to treat a chronic relapsing Pseudomonas aeruginosa infection of a prosthetic aortic graft. As there are currently no Danish laboratories offering phages for clinical therapy, and this case, to our knowledge represents the first applied phage therapy in Denmark, the practical and regulatory aspects of offering this treatment option in Denmark is briefly reviewed along with the clinical case.

AB - We present a case report detailing therapeutic application of two lytic antipseudomonal bacteriophages to treat a chronic relapsing Pseudomonas aeruginosa infection of a prosthetic aortic graft. As there are currently no Danish laboratories offering phages for clinical therapy, and this case, to our knowledge represents the first applied phage therapy in Denmark, the practical and regulatory aspects of offering this treatment option in Denmark is briefly reviewed along with the clinical case.

KW - Humans

KW - Bacteriophages

KW - Pseudomonas

KW - Pseudomonas Phages

KW - Blood Vessel Prosthesis

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=85184345543&partnerID=8YFLogxK

U2 - 10.61409/V09230617

DO - 10.61409/V09230617

M3 - Tidsskriftartikel

C2 - 38305316

SN - 0041-5782

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 3

M1 - V09230617

ER -

Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis

Abstract

Emneord

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater